Health & Science
Eli Lilly Acquires Struggling Cancer Biotech Kelonia for $3.2 Billion
h Will Eli Lilly's acquisition of Kelonia Therapeutics receive regulatory approval and close by the end of Q3 2026? 36% YES 📅 Resolution: 2026-09-30 🎯 Brier: 0.25 (h) 🔗 All Predictions What Happened ⚡ What Happened Eli Lilly is acquiring struggling cancer therapy startup Kelonia Therapeutics for $3.2 billion. Behind